Bay Biosciences LLC. is a leading global provider of fully characterized and consented human bio-specimens and bio-fluids for research. Founded in 2016, the company focuses on providing high-quality human biomaterials, fresh frozen human tissues, FFPE tissue blocks, and bio fluids like whole blood from diseased and normal subjects, serum, plasma, and other blood products. With a specialization in characterized and documented human bio-specimens for research and development projects, Bay BioSciences is a key player in the biopharma, biotechnology, pharmaceutical, and clean energy industries.
The company's offerings cater to the needs of research and development in various fields including translational medicine, genetics, drug discovery, biomarker research, companion, and molecular diagnostics. Bay BioSciences serves as a leading global biobank, providing vital products and services that facilitate breakthroughs in the aforementioned industries.
Despite the absence of information regarding the headquarter location and the last investment details, Bay Biosciences LLC.'s dedication to providing essential human bio-specimens and bio-fluids for research positions it as a noteworthy player in the biotechnology space, with potential opportunities for partnerships and investments in the future.
There is no investment information
No recent news or press coverage available for Bay Biosciences LLC..